Global Health Limited to hold analyst meeting on June 04

Global Health Limited has scheduled a virtual one-on-one meeting with Prudent Corporate Advisory Ltd on June 04, 2026. The company stated that no unpublished price sensitive information (UPSI) will be shared during this interaction, in accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The management of Global Health Limited will engage with the institutional investor as per the schedule below:

Parameter	Details
Investor/Analyst	Prudent Corporate Advisory Ltd
Date of Meeting	June 04, 2026
Type of Meeting	One to One
Mode of Meeting	Virtual

The intimation, signed by Rahul Ranjan, Company Secretary & Compliance Officer, was submitted to BSE Limited and the National Stock Exchange of India Limited. Global Health Limited noted that the meeting schedule is subject to change in case of any unforeseen circumstances involving the analysts, investors, or the company.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.67%	+2.67%	+5.85%	+3.26%	+3.60%	+198.58%

Global Health Limited has announced that its management will meet with analysts and institutional investors on May 27 and May 28, 2026. The disclosure was made in accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The schedule includes two specific meetings with major financial institutions. The first meeting is set for May 27, 2026, with ICICI Prudential AMC Ltd. This session will be a one-to-one interaction held in person in Gurugram. The second meeting is scheduled for May 28, 2026, with IIFL Capital Asset Management Limited. This will also be a one-to-one meeting but will be conducted virtually.

Meeting Schedule

Name	Date of Meeting	Type of Meeting	Mode of Meeting	Location
ICICI Prudential AMC Ltd	May 27, 2026	One to One	In Person	Gurugram
IIFL Capital Asset Management Limited	May 28, 2026	One to One	Virtual	NA

The company clarified that no unpublished price sensitive information is proposed to be shared during these interactions. Global Health Limited also noted that the schedule is subject to change in the event of any unforeseen circumstances involving the analysts, investors, or the company.